West Pharmaceutical Services, Inc.WSTNYSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank36
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P36
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -5.67% |
| Q3 2025 | 6.59% |
| Q2 2025 | 46.77% |
| Q1 2025 | -30.73% |
| Q4 2024 | -4.28% |
| Q3 2024 | 23.03% |
| Q2 2024 | -3.18% |
| Q1 2024 | -15.14% |
| Q4 2023 | -14.75% |
| Q3 2023 | 3.83% |
| Q2 2023 | 11.17% |
| Q1 2023 | 36.23% |
| Q4 2022 | -14.81% |
| Q3 2022 | -35.97% |
| Q2 2022 | 8.12% |
| Q1 2022 | 18.18% |
| Q4 2021 | -16.46% |
| Q3 2021 | -6.32% |
| Q2 2021 | 24.02% |
| Q1 2021 | 53.38% |
| Q4 2020 | 19.82% |
| Q3 2020 | -10.48% |
| Q2 2020 | 22.77% |
| Q1 2020 | 17.44% |
| Q4 2019 | 13.16% |
| Q3 2019 | -15.56% |
| Q2 2019 | 20.00% |
| Q1 2019 | 7.14% |
| Q4 2018 | -6.67% |
| Q3 2018 | -1.32% |
| Q2 2018 | 28.81% |
| Q1 2018 | 1850.74% |
| Q4 2017 | -104.88% |
| Q3 2017 | 30.19% |
| Q2 2017 | -36.14% |
| Q1 2017 | 56.60% |
| Q4 2016 | 3.92% |
| Q3 2016 | -16.39% |
| Q2 2016 | 96.77% |
| Q1 2016 | -32.61% |